Eveliqure Biotechnologies GMBH

Wien, Wien

UEI
ZKEJW1JEKBQ9
CAGE
6311N
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
International Organization
SAM.gov registration date
Physical address
Solaris, Karl-Farkas-Gasse 22, 1030 Wien, Austria

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $4,683,173
FY2024 $198,329
FY2023 $3,490,104

Contract awards

Quick answers

Is Eveliqure Biotechnologies GMBH registered in SAM.gov?

Yes. Eveliqure Biotechnologies GMBH's SAM.gov registration is active through April 27, 2027.

How much has Eveliqure Biotechnologies GMBH received in federal contracts?

Federal contracts obligated $4,683,173 to Eveliqure Biotechnologies GMBH in fiscal year 2025 and $8,371,606 in fiscal years 2023 through 2027.

How does Eveliqure Biotechnologies GMBH rank among federal contractors?

Eveliqure Biotechnologies GMBH ranked #38 in PSC AN12 in FY2025.

What is Eveliqure Biotechnologies GMBH's most recent federal award?

Eveliqure Biotechnologies GMBH's most recent federal contract award is To advance the development of the shigetec vaccine through cgmp manufacturing and release of additional cgmp lots for… (75N93020C00048), from National Institute of Allergy and Infectious Diseases (NIH), on September 1, 2020.

On GovTribe

See Eveliqure Biotechnologies GMBH's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors